These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant. Harrison DH, Bohren KM, Petsko GA, Ringe D, Gabbay KH. Biochemistry; 1997 Dec 23; 36(51):16134-40. PubMed ID: 9405046 [Abstract] [Full Text] [Related]
5. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites. El-Kabbani O, Old SE, Ginell SL, Carper DA. Mol Vis; 1999 Sep 03; 5():20. PubMed ID: 10493777 [Abstract] [Full Text] [Related]
7. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase. Nakano T, Petrash JM. Biochemistry; 1996 Aug 27; 35(34):11196-202. PubMed ID: 8780524 [Abstract] [Full Text] [Related]
8. Studies of the enzymic mechanism of Candida tenuis xylose reductase (AKR 2B5): X-ray structure and catalytic reaction profile for the H113A mutant. Kratzer R, Kavanagh KL, Wilson DK, Nidetzky B. Biochemistry; 2004 May 04; 43(17):4944-54. PubMed ID: 15109252 [Abstract] [Full Text] [Related]
9. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites. El-Kabbani O, Wilson DK, Petrash M, Quiocho FA. Mol Vis; 1998 Sep 29; 4():19. PubMed ID: 9756955 [Abstract] [Full Text] [Related]
10. High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group. Steuber H, Zentgraf M, Podjarny A, Heine A, Klebe G. J Mol Biol; 2006 Feb 10; 356(1):45-56. PubMed ID: 16337231 [Abstract] [Full Text] [Related]
14. Electrostatic stabilization in a pre-organized polar active site: the catalytic role of Lys-80 in Candida tenuis xylose reductase (AKR2B5) probed by site-directed mutagenesis and functional complementation studies. Kratzer R, Nidetzky B. Biochem J; 2005 Jul 15; 389(Pt 2):507-15. PubMed ID: 15799715 [Abstract] [Full Text] [Related]
16. Structure of xylose reductase bound to NAD+ and the basis for single and dual co-substrate specificity in family 2 aldo-keto reductases. Kavanagh KL, Klimacek M, Nidetzky B, Wilson DK. Biochem J; 2003 Jul 15; 373(Pt 2):319-26. PubMed ID: 12733986 [Abstract] [Full Text] [Related]
17. Oxidized aldose reductase: in vivo factor not in vitro artifact. Grimshaw CE, Lai CJ. Arch Biochem Biophys; 1996 Mar 01; 327(1):89-97. PubMed ID: 8615700 [Abstract] [Full Text] [Related]
19. Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity. El-Kabbani O, Carbone V, Darmanin C, Oka M, Mitschler A, Podjarny A, Schulze-Briese C, Chung RP. J Med Chem; 2005 Aug 25; 48(17):5536-42. PubMed ID: 16107153 [Abstract] [Full Text] [Related]
20. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features. Steuber H, Heine A, Podjarny A, Klebe G. J Mol Biol; 2008 Jun 20; 379(5):991-1016. PubMed ID: 18495158 [Abstract] [Full Text] [Related] Page: [Next] [New Search]